Akışa dön
85/100 Bullish 06.05.2026 · 03:13 Finrend AI ⏱ 1 dk 👁 6 TR

Italian Drug Company Chiesi to Acquire KalVista for $1.9 Billion - Reuters

Italian drugmaker Chiesi has agreed to acquire KalVista for $1.9 billion. The deal aims to strengthen KalVista's drug portfolio in the rare disease space. According to Reuters, the acquisition will be conducted in cash and is expected to close within 2024. This is not investment advice.

📊 GOOGL — Piyasa Yorumu

■ neutral · 60%

The news may have limited short-term impact on GOOGL as it is not directly related to its core technology and advertising business. Technical indicators show the RSI approaching overbought territory at 68, while the MACD has fallen below its signal line, increasing the likelihood of a short-term correction or sideways movement. The stock continues to trade above its 20- and 50-day moving averages, indicating that the overall trend remains upward but momentum is weakening. Therefore, it may be prudent to wait for further catalysts before determining a clear direction.

RSI 14
68.2
MACD
4.91
24h Δ
0.99%
Canlı Grafikler

🔗 İlgili haberler

🧬 Buna benzer

AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.